Compounds > loratadine

loratadine and rofecoxib

loratadine has been researched along with rofecoxib in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (50.00)29.6817
2010's2 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM1
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ1
Buonomo, A; De Lillo, M; Di Lillo, M; Manna, R; Nucera, E; Patriarca, G; Pollastrini, E; Roncallo, C; Schiavino, D1
Bourke, J; Roper, S1

Other Studies

4 other study(ies) available for loratadine and rofecoxib

ArticleYear
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
    Toxicology mechanisms and methods, 2008, Volume: 18, Issue:2-3

    Topics:

2008
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
    Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests

2013
Tolerance induction to rofecoxib in a patient with Bartter's syndrome.
    Allergy, 2004, Volume: 59, Issue:7

    Topics: Adult; Anti-Allergic Agents; Anti-Asthmatic Agents; Anti-Inflammatory Agents, Non-Steroidal; Bartter Syndrome; Cromolyn Sodium; Dose-Response Relationship, Drug; Drug Tolerance; Erythema; Female; Humans; Lactones; Loratadine; Pruritus; Sulfones

2004
In with the new: the determinants of prescribing innovation by general practitioners in Ireland.
    The European journal of health economics : HEPAC : health economics in prevention and care, 2012, Volume: 13, Issue:4

    Topics: Age Factors; Androstenes; Citalopram; Drug Prescriptions; Drug Utilization; Ethinyl Estradiol; General Practitioners; Humans; Information Dissemination; Insurance Claim Review; Ireland; Lactones; Loratadine; Nicotine; Omeprazole; Practice Patterns, Physicians'; Residence Characteristics; Sulfones; Therapies, Investigational; Time Factors

2012